Learn about switching from IVIg to SCIg for CIDP, including benefits, barriers, and support for home-based subcutaneous ...

Add Yahoo as a preferred source to see more of our stories on Google. Bioengineers in South Korea have succeeded in developing an intravenous needle (IV) that can bend and flex as it enters the human ...

Biologic drugs treat cancer, autoimmune diseases, blood disorders and more, but they're often too viscous to administer using commercially available needles and syringes. Now, though, researchers at ...

The subcutaneous formulation of Opdivo Qvantig reduces administration time to three to five minutes, compared to 30 minutes for the IV version. This formulation offers increased convenience, ...

This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...